02561

10.0903.90%
MJ

Michael J. Chang

Non-Executive Director

Mr. Michael J. Chang, M.B.A. serves as Non-Executive Director at VISEN Pharmaceuticals since June 26, 2026. He serves as Managing Partner at Vivo Capital, LLC since January 2021. Mr. Chang served as a Managing Director at Vivo Capital, LLC till January 2021. He had served as Principal at the firm. He joined Vivo Capital in 2012 as an Associate with a background in healthcare strategy and operations. He was Non-Executive Director at VISEN Pharmaceuticals (Shanghai) Co., Ltd. since December 01, 2023 until August 27, 2025. He led the post-investment management, risk and investment management and investor relations functions within the Firm. He had been Non-Executive Director at VISEN Pharmaceuticals since December 1, 2023 until September 2025. He also focuses on private investments. Mr. Chang worked at Johnson & Johnson, where he helped establish the strategy and commercial planning function for J&J’s China medical device business. Mr. Chang worked for Booz & Company and Fletcher Spaght as a strategy consultant and also co-founded a company in the vascular access space. He also has research experience at Harvard Medical School and University of California Irvine in brain tumor immunology and cancer genetics. Mr. Chang graduated from Harvard University with a B.A. in Economics, with a focus on Health Policy and an M.B.A. from Harvard Business School.

Positions